Skip to content
DataLookout
Menu

NCT04777175

A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Notable Primary completion date: Jan 1, 2024 to Jan 1, 2025v5
  3. Notable Primary completion date: Jan 1, 2023 to Jan 1, 2024
    • Start date: Jan 1, 2021 to Jan 1, 2023
    • Study completion date: Jan 12, 2023 to Jan 12, 2025
    v4
  4. Notable Primary completion date: Jan 1, 2022 to Jan 1, 2023
    • Study completion date: Jan 1, 2023 to Jan 12, 2023
    v3
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

PFS
Timeframe: January 2021- January 2021 (1 year)

Arms and interventions

KRAS mutation

patients carry with KRAS mutation

ALK fusion

patients carry with ALK fusion

ERBB2 mutation

patients carry with ERBB2 mutation

MET skipping/amplication

patients carry with MET skipping/amplication

RET fusion

patients carry with RET fusion

BRAF mutation

patients carry with BRAF mutation

Drugs: immunity therapy

Sites

2 sites in 1 country